Clinical Quiz: AGA Guideline for Fecal Microbiota-Based Therapies in Gastrointestinal Disease

On February 21, 2024, the American Gastroenterological Association (AGA) released the first comprehensive evidence-based guideline on the use of fecal microbiota-based therapies for gastrointestinal diseases. A guideline panel developed 7 recommendations intended to provide the basis for rational, informed decision-making for patients and healthcare professionals using fecal microbiota-based therapies for adults with recurrent Clostridioides difficile infection (CDI), severe to fulminant CDI, inflammatory bowel disease (IBD), and irritable bowel syndrome (IBS).

In this clinical quiz, test your knowledge of the clinical recommendations for the use of fecal microbiota-based therapies in the 2024 American Gastroenterological Association Clinical Practice Guideline on Fecal Microbiota-Based Therapies for Select Gastrointestinal Diseases.

Reference:

1. ^{Peery AF, Kelly CR, Kao D, et al. American Gastroenterological Association Clinical Practice Guideline on Fecal Microbiota-Based Therapies for Select Gastrointestinal Diseases. Gastroenterology. https://www.gastrojournal.org/article/S0016-5085(24)00041-6/fulltext}